Revolution Medicines Soars as Darovasertib's Stellar Data Paves Way for Phase 3 in Uveal Melanoma
Wells Fargo Crowns Axsome Therapeutics a Biotech Heavyweight with 'Overweight' Rating on Blockbuster Alzheimer's Potential
Groundbreaking Cancer Drug Ivonescimab Propels Akeso Shares After Major Clinical Trial Success
Talphaera's Q2 2025: Unpacking Financials & Pioneering Biotech Advancements